OracleBio will be exhibiting at the 2018 Biomarkers and Immuno-Oncology World Congress, which takes place from the 11th to 13th June in Boston.
OracleBio offers a range of digital pathology services to support pre-clinical and clinical immuno-oncology R&D. With extensive experience of quantifying immune cell content and spatial relationships within the tumor microenvironment across multiplex IHC and IF stained tissues, we deliver cell-by-cell data for improved study interpretation and decision making. Click here for more information on how our services can support your immuno-oncology research.
Now in its fourteenth year, the Biomarkers and Immuno-Oncology World Congress is dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. To find out more about the congress, please click here.
OracleBio’s CSO, Lorcan Sherry, and Business Development Manager, Hannah Thomson will be at Booth 29 throughout the meeting. If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with Lorcan and Hannah during the event, please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: